Gaxos.ai Inc. (NASDAQ: GXAI), a developer of artificial intelligence applications across multiple sectors, reported record consolidated revenue of approximately $2.81 million for the third quarter ended September 30, 2026, an increase of 464.9% from $500,000 in the prior-year period and 14.5% from $2.46 million in the second quarter. The results, disclosed in the company’s latest financial and operating update, mark a sharp acceleration in top-line growth for the AI applications developer.
The company also narrowed its basic and diluted net loss per share attributable to common shareholders to $0.08, compared with $0.14 a year earlier. Advertising and marketing expenses declined 16.7% sequentially to $2.62 million, while revenue generated per advertising dollar improved approximately 38% to $1.08 from $0.78 in the previous quarter. That combination of falling marketing spend and rising revenue suggests Gaxos is extracting more value from each customer acquisition dollar, a key metric for investors assessing the sustainability of its growth.
Gaxos ended the quarter with approximately $13.3 million in cash and short-term investments, up from $11.44 million at June 30, 2026. The company received approximately $3.17 million in net proceeds from warrant exercises during the quarter, issuing approximately 3 million common shares, and did not issue shares through its at-the-market offering program. The absence of ATM issuance may reassure shareholders concerned about dilution.
CEO Vadim Mats said the company remains focused on improving customer acquisition efficiency and expanding products and channels with favorable contribution economics. The strategy appears to be reflected in the quarter’s advertising efficiency gains, which came alongside revenue growth.
Gaxos develops artificial intelligence applications designed to address opportunities across consumer and enterprise markets. Its operations include Gaxos Labs, which develops and commercializes AI-powered applications, and RNK Health, a majority-owned subsidiary offering personalized weight loss, longevity, and performance treatments. Gaxos also holds a strategic minority investment in America First Defense.AI, a defense-technology company developing next-generation counter-UAS and robotic platforms.
The quarterly update matters for readers tracking the commercial viability of AI application developers, where revenue growth often comes at the expense of heavy marketing spending. Gaxos’s ability to grow revenue while reducing advertising expenses and improving revenue per advertising dollar could indicate a more capital-efficient model. For the broader AI sector, the results offer a data point that demand for applied AI products may be translating into repeatable revenue. Investors can view the full press release at https://ibn.fm/oAHzV and find the latest news and updates relating to GXAI in the company’s newsroom at https://ibn.fm/GXAI. The announcement was distributed through InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN, which provides services including editorial syndication to 5,000+ outlets and social media distribution. Full terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
